246 related articles for article (PubMed ID: 19855396)
1. Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries.
Veith H; Southall N; Huang R; James T; Fayne D; Artemenko N; Shen M; Inglese J; Austin CP; Lloyd DG; Auld DS
Nat Biotechnol; 2009 Nov; 27(11):1050-5. PubMed ID: 19855396
[TBL] [Abstract][Full Text] [Related]
2. Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening data.
Sun H; Veith H; Xia M; Austin CP; Huang R
J Chem Inf Model; 2011 Oct; 51(10):2474-81. PubMed ID: 21905670
[TBL] [Abstract][Full Text] [Related]
3. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
Cheng F; Yu Y; Zhou Y; Shen Z; Xiao W; Liu G; Li W; Lee PW; Tang Y
J Chem Inf Model; 2011 Oct; 51(10):2482-95. PubMed ID: 21875141
[TBL] [Abstract][Full Text] [Related]
4. Hydroxylation and demethylation of the tricyclic antidepressant nortriptyline by cDNA-expressed human cytochrome P-450 isozymes.
Olesen OV; Linnet K
Drug Metab Dispos; 1997 Jun; 25(6):740-4. PubMed ID: 9193876
[TBL] [Abstract][Full Text] [Related]
5. RS-Predictor models augmented with SMARTCyp reactivities: robust metabolic regioselectivity predictions for nine CYP isozymes.
Zaretzki J; Rydberg P; Bergeron C; Bennett KP; Olsen L; Breneman CM
J Chem Inf Model; 2012 Jun; 52(6):1637-59. PubMed ID: 22524152
[TBL] [Abstract][Full Text] [Related]
6. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
7. RS-WebPredictor: a server for predicting CYP-mediated sites of metabolism on drug-like molecules.
Zaretzki J; Bergeron C; Huang TW; Rydberg P; Swamidass SJ; Breneman CM
Bioinformatics; 2013 Feb; 29(4):497-8. PubMed ID: 23242264
[TBL] [Abstract][Full Text] [Related]
8. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
Bu HZ; Magis L; Knuth K; Teitelbaum P
Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
[TBL] [Abstract][Full Text] [Related]
9. Harnessing machine learning to predict cytochrome P450 inhibition through molecular properties.
Zahid H; Tayara H; Chong KT
Arch Toxicol; 2024 Apr; ():. PubMed ID: 38619593
[TBL] [Abstract][Full Text] [Related]
10. Monitoring compound integrity with cytochrome P450 assays and qHTS.
MacArthur R; Leister W; Veith H; Shinn P; Southall N; Austin CP; Inglese J; Auld DS
J Biomol Screen; 2009 Jun; 14(5):538-46. PubMed ID: 19483146
[TBL] [Abstract][Full Text] [Related]
11. Effects of obesity on the cytochrome P450 enzyme system.
Kotlyar M; Carson SW
Int J Clin Pharmacol Ther; 1999 Jan; 37(1):8-19. PubMed ID: 10027478
[TBL] [Abstract][Full Text] [Related]
12. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes.
Plonka W; Stork C; Šícho M; Kirchmair J
Bioorg Med Chem; 2021 Sep; 46():116388. PubMed ID: 34488021
[TBL] [Abstract][Full Text] [Related]
13. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
Olesen OV; Linnet K
Br J Clin Pharmacol; 2000 Dec; 50(6):563-71. PubMed ID: 11136295
[TBL] [Abstract][Full Text] [Related]
14. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4.
Venkatakrishnan K; Greenblatt DJ; von Moltke LL; Schmider J; Harmatz JS; Shader RI
J Clin Pharmacol; 1998 Feb; 38(2):112-21. PubMed ID: 9549641
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes.
Olesen OV; Linnet K
Pharmacology; 1997 Nov; 55(5):235-43. PubMed ID: 9399333
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
17. Oxidative metabolism of bunitrolol by complementary DNA-expressed human cytochrome P450 isozymes in a human hepatoma cell line (Hep G2) using recombinant vaccinia virus.
Ono S; Tsutsui M; Gonzalez FJ; Satoh T; Masubuchi Y; Horie T; Suzuki T; Narimatsu S
Pharmacogenetics; 1995 Apr; 5(2):97-102. PubMed ID: 7663534
[TBL] [Abstract][Full Text] [Related]
18. Luminogenic cytochrome P450 assays.
Cali JJ; Ma D; Sobol M; Simpson DJ; Frackman S; Good TD; Daily WJ; Liu D
Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):629-45. PubMed ID: 16859410
[TBL] [Abstract][Full Text] [Related]
19. The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression.
Jann MW; Cohen LJ
Drug Metabol Drug Interact; 2000; 16(1):39-67. PubMed ID: 10820582
[TBL] [Abstract][Full Text] [Related]
20. Transfer learning for cytochrome P450 isozyme selectivity prediction.
Teramoto R; Kato T
J Bioinform Comput Biol; 2011 Aug; 9(4):521-40. PubMed ID: 21776607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
